Inventor
JALAN RAJIV
GB15 patents
⚠️ This page may combine multiple inventors who share the name “JALAN RAJIV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JALAN RAJIV
7 patentsUS9566257B2Feb 14, 2017
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JALAN RAJIV15 citations89
US8389576B2Mar 5, 2013
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JALAN RAJIV26 citations89
US9889176B2Feb 13, 2018
Treating renal and liver dysfunction with TLR4 antagonists
JALAN RAJIV2 citations67
US11714087B2Aug 1, 2023
Treatment of necroptosis
JALAN RAJIV0 citations58
US11752196B2Sep 12, 2023
Treatment of pyroptosis
JALAN RAJIV0 citations47
US8455220B2Jun 4, 2013
Biomarkers for assessing liver function
JALAN RAJIV0 citations44
US8415117B2Apr 9, 2013
Prognosis and therapy of liver failure
JALAN RAJIV0 citations30
UCL BUSINESS PLC
6 patentsUS10039735B2Aug 7, 2018
Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
UCL BUSINESS PLC19 citations89
US10610506B2Apr 7, 2020
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
UCL BUSINESS PLC5 citations81
US10525029B2Jan 7, 2020
Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
UCL BUSINESS PLC9 citations79
US11266620B2Mar 8, 2022
Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
UCL BUSINESS PLC2 citations72
US11040021B2Jun 22, 2021
Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
UCL BUSINESS PLC2 citations68
US9844568B2Dec 19, 2017
Porous carbon particles for use in the treatment or prevention of liver disease
UCL BUSINESS PLC0 citations42